Prosecution Insights
Last updated: July 17, 2026
Application No. 18/398,831

Sealing Feature for Prosthetic Heart Valve

Non-Final OA §102§103
Filed
Dec 28, 2023
Priority
Mar 31, 2023 — provisional 63/493,410
Examiner
WILLSE, DAVID H
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cephea Valve Technologies Inc.
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
81%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
393 granted / 583 resolved
-2.6% vs TC avg
Moderate +13% lift
Without
With
+13.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
28 currently pending
Career history
620
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
64.8%
+24.8% vs TC avg
§102
21.9%
-18.1% vs TC avg
§112
8.3%
-31.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 583 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification The disclosure is objected to because of the following informalities: In specification paragraph 0064, first line, “111c” should be --211c--; on the second line, “11d” should be --211d--. On page 13, eighteenth line, “couple” should read --coupled--. In paragraph 0078, second line, Applicant may want to delete the first occurrence of “valve”. In paragraph 0080, fourth line, “325a” should be --320a--; on the ninth line, “335” should be --335a--. In paragraph 00115, third line, “is it” should be --it is--. Appropriate correction is required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-4, 9-10, and 12-14 are rejected under 35 U.S.C. 102(a)(1) as being clearly anticipated by Oba et al., US 2016/0310268 A1, which discloses an outer frame connected to an inner frame coupled with a plurality of leaflets functioning similar to a natural heart valve (Figures 7, 12-13, 24-25; paragraphs 0013-0014, 0024, 0062, 0107) and a sealing feature 330 extending radially outwardly in a direction substantially orthogonal to a longitudinal axis of the inner frame, coupled to points on the inner and outer frames, and comprising a plurality of layers (Figures 7, 9, 14-17, 24-25; paragraphs 0109-0115). Regarding claims 2-4, sealing feature 330 may involve angular offsets of weave patterns in first and second layers (Figure 16; paragraph 0113). Regarding claims 9-10 and 12, overlapping and non-overlapping regions are formed by the flexible material 336 circumscribing orifice 332 and by struts 340 (Figures 14-15; paragraphs 0111-0112). Regarding claims 13-14, the layers are coupled to outer frame 308 (paragraph 0110) and are innately coupled to each other in order to maintain beneficial angular orientations (paragraphs 0111, 0113) and the like. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 5-8, 11, and 15-17 are rejected under 35 U.S.C. 103 as being unpatentable over Oba et al., US 2016/0310268 A1. Regarding claim 5, indicia such as notch alignment would have been obvious in order to facilitate manufacture such that proper fiber orientations for increasing “the ability of the sealing member to resist enlargement of the orifice 332” (paragraph 0113, last sentence) are attained. Regarding claims 6 and 8, angular offsets of 45° for two stacked layers would have been obvious to one of ordinary skill in the art at the effective filing date of the instant invention so as to more evenly and symmetrically provide reinforcement for orifice 332 (paragraph 0113). Regarding claim 7, sealing feature 330 layers are substantially impermeable to blood flowing through a respective layer (paragraphs 0084, 0109-0110). Regarding claims 11 and 16-17, a second or non-overlapping region positioned radially inwardly relative to an overlap region would have been an obvious variant in order to provide thickened reinforcement (in inflow and/or outflow directions) for the suturing or attachment to frame 308 (paragraph 0110). Regarding claim 15, a double running stitch pattern would have been obvious from the seams or stitching 348 (Figure 17; paragraph 0114) in order to provide a durable sealing feature 330 (paragraphs 0109-0110). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to David H. Willse, whose telephone number is 571-272-4762. The examiner can normally be reached on Monday through Thursday. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor Melanie Tyson can be reached at telephone number 571-272-9062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://portal.uspto.gov/external/portal. Should you have questions about access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, Applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. /DAVID H WILLSE/ Primary Examiner, Art Unit 3774
Read full office action

Prosecution Timeline

Dec 28, 2023
Application Filed
Jul 01, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678302
AUTOMATED HAND
1y 8m to grant Granted Jul 14, 2026
Patent 12653700
ORTHOPAEDIC JOINT AND ORTHOPAEDIC DEVICE
5y 1m to grant Granted Jun 16, 2026
Patent 12648852
PUMP AND VALVE SYSTEM FOR HYDRAULIC PRESSURIZATION OF IMPLANTS
6y 5m to grant Granted Jun 09, 2026
Patent 12648844
DEVICE FOR TRANSPLANTING A DESCEMET'S MEMBRANE
4y 9m to grant Granted Jun 09, 2026
Patent 12605262
INFLATABLE LIMB PROSTHESIS
1y 4m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
81%
With Interview (+13.4%)
3y 10m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 583 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month